Skip to main content
Clinical Trials/NCT00552006
NCT00552006
Completed
Not Applicable

A Randomized Controlled Clinical Trial (RCCT) to Test the Effectiveness of Narrative Exposure Therapy (NET) Versus an Attention Control Condition (AC) in Reducing Trauma Related Symptoms in Formerly Abducted Children and Former Child Soldiers Suffering From Posttraumatic Stress Disorder (PTSD)

University of Konstanz1 site in 1 country85 target enrollmentNovember 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stress Disorders, Post-Traumatic
Sponsor
University of Konstanz
Enrollment
85
Locations
1
Primary Endpoint
Load of traumatic symptoms measured via the CAPS (Clinician-administered PTSD scale)
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

In the aftermath of traumatic experiences like natural disasters or man-caused traumatic events, such as war experiences, a substantial part of the affected individuals develop a number of psychological symptoms. The characteristic symptom pattern occurring in the aftermath of traumatic events is called posttraumatic stress disorder (PTSD) and includes functional impairment of the affected individuals. The investigators want to test whether Narrative Exposure Therapy (NET) is an effective tool in reducing trauma related symptoms in formerly abducted children and youths and former child soldiers, when applied by lay personnel.

Registry
clinicaltrials.gov
Start Date
November 2007
End Date
November 2009
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of Konstanz

Eligibility Criteria

Inclusion Criteria

  • clinical diagnosis of PTSD (Post-Traumatic Stress Disorder) derived from expert interviews
  • member of the group of formerly abducted people or former child soldiers

Exclusion Criteria

  • current substance dependence
  • mental retardation
  • psychotic disorder

Outcomes

Primary Outcomes

Load of traumatic symptoms measured via the CAPS (Clinician-administered PTSD scale)

Time Frame: 3 months, 6 months and 1 year after completion of treatment

Secondary Outcomes

  • Load of depressive symptoms measured via the MINI, strength of suicidal ideation measured via the MINI, functionality measured via the CAPS, feelings of guilt measured via the CAPS, stigmatization measured via an adapted version of the PSQ(3 months, 6 months and 1 year after completion of treatment)

Study Sites (1)

Loading locations...

Similar Trials